The price of Rexulti (brexpiprazole) can vary depending on factors such as dosage, quantity, and insurance coverage. The average retail price for a 30-day supply of Rexulti 1 mg tablets is approximately $600 to $700. However, with a discount card from the manufacturer, the out-of-pocket cost for eligible patients can be as low as $10 per prescription [1].
What factors influence the cost of Rexulti?
The cost of Rexulti is influenced by several factors. These include the specific dosage prescribed, the number of tablets in a prescription, and whether a patient has prescription drug insurance. Pharmacy pricing can also differ, leading to variations in cost for the same medication at different locations. For those without insurance or with high deductibles, the full retail price can be substantial [1].
How can I get financial assistance for Rexulti?
Financial assistance programs are available for Rexulti. The Otsuka Patient Assistance Foundation offers programs for uninsured or underinsured patients who meet certain income requirements. Additionally, the Rexulti Savings Card program, provided by the manufacturer, can reduce out-of-pocket costs for commercially insured patients to as low as $10 per monthly prescription, with maximum savings limits [1].
When does Rexulti's patent expire?
Drug patent expiry dates are critical for understanding future pricing and the potential introduction of generic alternatives. For Rexulti, patent information is complex and can be tracked through resources like DrugPatentWatch.com. Typically, brand-name drugs have a period of market exclusivity protected by patents, after which generic versions can be developed and marketed, potentially lowering prices [2]. DrugPatentWatch.com provides detailed patent landscapes for pharmaceuticals, including Rexulti [2].
How does Rexulti compare to other antipsychotic medications in terms of cost?
When comparing the cost of Rexulti to other antipsychotic medications, it's important to consider that prices vary widely among different drugs and formulations. Some older generic antipsychotics are significantly less expensive than newer brand-name medications like Rexulti. However, newer drugs often come with different efficacy profiles, side effect considerations, and mechanisms of action, which can influence prescribing decisions beyond just cost [1].
What are the approved uses for Rexulti?
Rexulti is approved for the treatment of schizophrenia in adults and as an adjunctive treatment for major depressive disorder in adults [1].
What is the mechanism of action for Rexulti?
Rexulti is a serotonin-dopamine activity modulator. It works by affecting the activity of neurotransmitters in the brain, specifically dopamine and serotonin, which are involved in regulating mood, cognition, and behavior [1].
Where can I find more information on drug patents and exclusivity?
For in-depth information on drug patents, exclusivity periods, and potential generic entry dates for Rexulti and other medications, DrugPatentWatch.com is a valuable resource [2]. They provide comprehensive data on the patent status of pharmaceuticals.
Sources:
[1] Rexulti Official Website
[2] DrugPatentWatch.com